Category - Executive Moves

Executive Moves

PharmaJet names Paul LaBarre as VP global business development

PharmaJet named Paul LaBarre as VP of global business development to lead business development and commercialization strategies, replacing Melissa Malhame, who transitioned to a strategic advisory role for the company...

June 15, 2021

Executive Moves

Accelmed Partners bolsters senior HealthTech executive team

Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of...

June 14, 2021

Executive Moves

iBio adds veteran biopharmaceutical executive Evert Schimmelpennink to board

iBio (NYSEA:IBIO) appointed Evert (Eef) Schimmelpennink to its board of directors, effective immediately. In an executive leadership career spanning more than 20 years, Mr. Schimmelpennink has expertise across corporate...

June 10, 2021

Executive Moves

RNA Disease Diagnostics adds John Erickson Jr. as president

RNA Disease Diagnostics (RNADD) appointed John Erickson, Jr. to the newly created position of president to lead day-to-day operations. He will report directly to company co-founder and executive chairman, Allan Oberman...

June 1, 2021

Executive Moves

Doug Kleinberg joins BTIG healthcare investment banking

Doug Kleinberg has joined BTIG’s healthcare investment banking unit as a managing director to focus on investment banking opportunities for corporate clients across biotech, biopharma and pharma. Mr. Kleinberg has over...

May 24, 2021

Executive Moves

Roth adds John Boris to healthcare investment banking team

John Boris has joined Roth Capital Partners’ healthcare investment banking team as a managing director. Prior to joining Roth, Mr. Boris was the managing partner of JTB Capital Management, where he invested in private...

May 19, 2021

Executive Moves

Ripple Therapeutics appoints renowned ophthalmologist Dr. Jonathan Talamo to board

Closely-held Ripple Therapeutics named Jonathan Talamo, M.D., an internationally known ophthalmologist, innovator and consultant to the industry with more than 25 years of experience in healthcare, to the board. Dr...

May 4, 2021

Executive Moves

Former U.S. assistant secretary for health Admiral Joxel Garcia joins Flurotest advisory board

Former U.S. assistant secretary for health and four-star Admiral Joxel Garcia, M.D. joined FluroTest’s (TSXV:TEST; OTCQB:FLURF) advisory board. Dr. Garcia will help support FluroTest business operations...

April 6, 2021

Executive Moves

Oppenheimer expands healthcare investment banking team

Oppenheimer (NYSE:OPY) continued to build out its healthcare leadership team, adding three members to its healthcare investment banking team: Jonathan Fassberg, in the newly created role of vice chairman; Brian Korb, as...

March 24, 2021

Executive Moves

KA Imaging adds world renowned radiologist Philip Templeton as CMO

X-ray manufacturer, KA Imaging, appointed Dr. Philip Templeton, M.D., to the newly created position of chief medical officer (CMO). A board certified radiologist, Dr. Templeton brings over 38 years of academic and...

March 8, 2021

Category - Executive Moves

PharmaJet names Paul LaBarre as VP global business development

Accelmed Partners bolsters senior HealthTech executive team

iBio adds veteran biopharmaceutical executive Evert Schimmelpennink to board

RNA Disease Diagnostics adds John Erickson Jr. as president

Doug Kleinberg joins BTIG healthcare investment banking

Roth adds John Boris to healthcare investment banking team

Ripple Therapeutics appoints renowned ophthalmologist Dr. Jonathan Talamo to board

Former U.S. assistant secretary for health Admiral Joxel Garcia joins Flurotest advisory board

Oppenheimer expands healthcare investment banking team

KA Imaging adds world renowned radiologist Philip Templeton as CMO

General

More